Alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
prevents	prevents	O	O	O	O
mitochondrial	mitochondrial	O	O	OTHERS	I
damage	damage	O	O	OTHERS	I
and	and	O	O	O	O
neurotoxicity	neurotoxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
experimental	experimental	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
study	study	O	O	O	O
investigates	investigates	O	O	O	O
if	if	O	O	O	O
alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
is	is	O	O	O	O
neuroprotective	neuroprotective	O	O	O	O
against	against	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
induced	induced	O	O	O	O
neurotoxicity	neurotoxicity	O	DISEASE	OTHERS	I
,	,	O	O	O	O
if	if	O	O	O	O
mitochondrial	mitochondrial	O	O	OTHERS	I
damage	damage	O	O	OTHERS	I
plays	plays	O	O	O	O
a	a	O	O	O	O
critical	critical	O	O	O	O
role	role	O	O	O	O
in	in	O	O	O	O
toxic	toxic	O	O	OTHERS	I
neurodegenerative	neurodegenerative	O	O	OTHERS	I
cascade	cascade	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
if	if	O	O	O	O
neuroprotective	neuroprotective	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
depend	depend	O	O	O	O
on	on	O	O	O	O
mitochondria	mitochondria	O	O	O	O
protection	protection	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
used	used	O	O	O	O
an	an	O	O	O	O
in	in	O	O	O	O
vitro	vitro	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
induced	induced	O	O	O	O
peripheral	peripheral	O	DISEASE	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
that	that	O	O	O	O
closely	closely	O	O	O	O
mimic	mimic	O	O	O	O
the	the	O	O	O	O
in	in	O	O	O	O
vivo	vivo	O	O	O	O
condition	condition	O	O	O	O
by	by	O	O	O	O
exposing	exposing	O	O	O	O
primary	primary	O	O	O	O
cultures	cultures	O	O	O	O
of	of	O	O	O	O
dorsal	dorsal	O	O	O	O
root	root	O	O	O	O
ganglion	ganglion	O	O	O	O
(	(	O	O	O	O
DRG	drg	O	O	O	O
)	)	O	O	O	O
sensory	sensory	O	O	O	O
neurons	neurons	O	O	O	O
to	to	O	O	O	O
paclitaxel	paclitaxel	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
two	two	O	O	O	O
widely	widely	O	O	O	O
used	used	O	O	O	O
and	and	O	O	O	O
highly	highly	O	O	O	O
effective	effective	O	O	O	O
chemotherapeutic	chemotherapeutic	O	O	O	O
drugs	drugs	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
approach	approach	O	O	O	O
allowed	allowed	O	O	O	O
investigating	investigating	O	O	O	O
the	the	O	O	O	O
efficacy	efficacy	O	O	O	O
of	of	O	O	O	O
alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
in	in	O	O	O	O
preventing	preventing	O	O	O	O
axonal	axonal	O	O	OTHERS	I
damage	damage	O	O	OTHERS	I
and	and	O	O	O	O
apoptosis	apoptosis	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
function	function	O	O	O	O
and	and	O	O	O	O
ultrastructural	ultrastructural	O	O	O	O
morphology	morphology	O	O	O	O
of	of	O	O	O	O
mitochondria	mitochondria	O	O	O	O
after	after	O	O	O	O
exposure	exposure	O	O	O	O
to	to	O	O	O	O
toxic	toxic	O	O	O	O
agents	agents	O	O	O	O
and	and	O	O	O	O
alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
.	.	O	O	O	O

Our	our	O	O	O	O
results	results	O	O	O	O
demonstrate	demonstrate	O	O	O	O
that	that	O	O	O	O
both	both	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
paclitaxel	paclitaxel	CHEMICALS	O	OTHERS	I
cause	cause	O	O	O	O
early	early	O	O	O	O
mitochondrial	mitochondrial	O	O	OTHERS	I
impairment	impairment	O	O	OTHERS	I
with	with	O	O	O	O
loss	loss	O	O	O	O
of	of	O	O	O	O
membrane	membrane	O	O	O	O
potential	potential	O	O	O	O
and	and	O	O	O	O
induction	induction	O	O	O	O
of	of	O	O	O	O
autophagic	autophagic	O	O	O	O
vacuoles	vacuoles	O	O	O	O
in	in	O	O	O	O
neurons	neurons	O	O	O	O
.	.	O	O	O	O

Alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
exerts	exerts	O	O	O	O
neuroprotective	neuroprotective	O	O	O	O
effects	effects	O	O	O	O
against	against	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
induced	induced	O	O	O	O
neurotoxicity	neurotoxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
sensory	sensory	O	O	O	O
neurons	neurons	O	O	O	O
:	:	O	O	O	O
it	it	O	O	O	O
rescues	rescues	O	O	O	O
the	the	O	O	O	O
mitochondrial	mitochondrial	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
induces	induces	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
frataxin	frataxin	O	O	O	O
,	,	O	O	O	O
an	an	O	O	O	O
essential	essential	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
protein	protein	O	O	O	O
with	with	O	O	O	O
anti-oxidant	anti-oxidant	O	O	O	O
and	and	O	O	O	O
chaperone	chaperone	O	O	O	O
properties	properties	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
conclusion	conclusion	O	O	O	O
mitochondrial	mitochondrial	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
is	is	O	O	O	O
an	an	O	O	O	O
early	early	O	O	O	O
common	common	O	O	O	O
event	event	O	O	O	O
both	both	O	O	O	O
in	in	O	O	O	O
paclitaxel	paclitaxel	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
neurotoxicity	neurotoxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
protects	protects	O	O	O	O
sensory	sensory	O	O	O	O
neurons	neurons	O	O	O	O
through	through	O	O	O	O
its	its	O	O	O	O
anti-oxidant	anti-oxidant	O	O	O	O
and	and	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
regulatory	regulatory	O	O	O	O
functions	functions	O	O	O	O
,	,	O	O	O	O
possibly	possibly	O	O	O	O
inducing	inducing	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
frataxin	frataxin	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
findings	findings	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
alpha-lipoic	alpha-lipoic	O	O	O	O
acid	acid	O	O	O	O
might	might	O	O	O	O
reduce	reduce	O	O	O	O
the	the	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
developing	developing	O	O	O	O
peripheral	peripheral	O	O	OTHERS	I
nerve	nerve	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
undergoing	undergoing	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
and	and	O	O	O	O
encourage	encourage	O	O	O	O
further	further	O	O	O	O
confirmatory	confirmatory	O	O	O	O
clinical	clinical	O	O	O	O
trials	trials	O	O	O	O
.	.	O	O	O	O

